Caroline Humer, U.S. Health and Pharma editor, and Michelle Gershberg, Global Health editor, dive into Robert F. Kennedy Jr.'s proposed cuts to major health agencies like the FDA and CDC. They discuss the potential fallout from reducing approximately 10,000 jobs and how this could affect the country’s readiness for health threats like measles outbreaks. The conversation highlights industry reactions, concerns over leadership changes impacting drug approvals, and the risk posed by rising vaccine hesitancy among families.
